Insiders · ABCL

ABCL insider transactions

AbCellera Biologics Inc. (ABCL) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

ABCL insiders

Everyone who has filed a Form 3, 4, 5 or 144 at AbCellera Biologics Inc., latest first. Follow anyone to get their next filing.

• Michael R HaydenDirector+$1.33M-$2.55M
• John S. MontalbanoDirector+$1.09M
• Andrew BoothChief Financial Officer+$2.11M-$30.6M
• Lynn SeelyDirector, since June 2026
• Victor SandorDirector, since June 2026
• Stephen QuakeDirector, since November 2025
• Thermopylae Holdings Ltd.10% owner+$21.5M-$135M
• Hansen Carl L. G.Chief Executive Officer, Director, 10% owner-$145M
• Tryn StimartChief Legal Officer-$25.5M
• Veronique LecaultChief Technology Officer, Director+$3.37M-$25.5M
• Andrew LoDirector, since December 2021+$1.22M
• Ester FalconerOfficer, since January 2021-$25.5M
• John HamerDirector-$5.08M
• DCVC Bio, L.P.10% owner

Recent Form 3, 4, and 5 filings for ABCL

• 76d
  Director Hayden Michael R bought $570,442 worth of shares (53,613 units at $10.64) (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 82d
  Director Montalbano John S. bought $110,300 worth of shares (10,000 units at $11.03), increasing direct ownership by 4% to 251,000 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 86d
  Chief Financial Officer Booth Andrew bought $383,904 worth of shares (37,200 units at $10.32), increasing direct ownership by 8% to 482,800 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 86d
  Director Hayden Michael R bought $481,033 worth of shares (46,387 units at $10.37) (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 87d
  Director Hayden Michael R gifted 50,000 shares (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 125d
  SEC Form 4 filed by Director Seely Lynn

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 125d
  SEC Form 3 filed by new insider Seely Lynn

  3 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 125d
  SEC Form 4 filed by Director Sandor Victor

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 149d
  SEC Form 4 filed by Director Hayden Michael R

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 149d
  SEC Form 4 filed by Director Quake Stephen

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 149d
  SEC Form 4 filed by Director Montalbano John S.

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 150d
  SEC Form 3 filed by new insider Sandor Victor

  3 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 158d
  Chief Financial Officer Booth Andrew exercised 250,000 shares at a strike of $0.19, increasing direct ownership by 128% to 445,600 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 174d
  Director Montalbano John S. bought $95,400 worth of shares (20,000 units at $4.77), increasing direct ownership by 9% to 241,000 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 251d
  Large owner Thermopylae Holdings Ltd. bought $130,720 worth of shares (38,000 units at $3.44), increasing direct ownership by 0.07% to 56,134,097 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 254d
  Large owner Thermopylae Holdings Ltd. bought $580,284 worth of shares (177,457 units at $3.27), increasing direct ownership by 0.32% to 56,096,097 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 254d
  Chief Financial Officer Booth Andrew bought $145,692 worth of shares (42,600 units at $3.42), increasing direct ownership by 28% to 195,600 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 307d
  SEC Form 4 filed by Chief Financial Officer Booth Andrew

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 307d
  SEC Form 4 filed by Chief Executive Officer Hansen Carl L. G.

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 307d
  SEC Form 4 filed by Chief Legal Officer Stimart Tryn

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 307d
  SEC Form 4 filed by Chief Technology Officer Lecault Veronique

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 324d
  SEC Form 4 filed by Director Quake Stephen

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 324d
  New insider Quake Stephen claimed ownership of 1,100,436 shares (SEC Form 3)

  3 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 324d
  Large owner Thermopylae Holdings Ltd. gifted 225,000 shares, decreasing direct ownership by 0.40% to 55,918,640 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 347d
  Director Montalbano John S. bought $178,460 worth of shares (50,000 units at $3.57), increasing direct ownership by 29% to 221,000 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 495d
  SEC Form 4 filed by Director Hayden Michael R

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 510d
  SEC Form 4 filed by Director Montalbano John S.

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 510d
  SEC Form 4 filed by Director Lo Andrew

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 607d
  Large owner Thermopylae Holdings Ltd. bought $742,243 worth of shares (343,631 units at $2.16), increasing direct ownership by 0.62% to 56,143,640 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 608d
  Director Montalbano John S. bought $57,500 worth of shares (25,000 units at $2.30), increasing direct ownership by 17% to 171,000 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 611d
  Director Montalbano John S. bought $140,568 worth of shares (60,000 units at $2.34), increasing direct ownership by 70% to 146,000 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 674d
  SEC Form 4 filed by Chief Legal Officer Stimart Tryn

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 674d
  SEC Form 4 filed by Chief Operating Officer Lecault Veronique

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 674d
  SEC Form 4 filed by Chief Financial Officer Booth Andrew

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 674d
  SEC Form 4 filed by Chief Executive Officer Hansen Carl L. G.

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 703d
  Large owner Thermopylae Holdings Ltd. gifted 286,000 shares, decreasing direct ownership by 0.51% to 55,800,009 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 712d
  Chief Executive Officer Hansen Carl L. G. exercised 56,125 shares at a strike of $2.70, increasing direct ownership by 7% to 898,000 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 775d
  Chief Executive Officer Hansen Carl L. G. exercised 56,125 shares at a strike of $2.70, increasing direct ownership by 7% to 841,875 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 801d
  Large owner Thermopylae Holdings Ltd. bought $739,977 worth of shares (283,516 units at $2.61), increasing direct ownership by 0.51% to 56,086,009 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 867d
  Chief Operating Officer Lecault Veronique exercised 83,334 shares at a strike of $0.19, increasing direct ownership by 4% to 2,123,456 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 867d
  SEC Form 4 filed by Director Hayden Michael R

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 867d
  SEC Form 4 filed by Director Lo Andrew

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 867d
  SEC Form 4 filed by Director Montalbano John S.

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 888d
  Hansen Carl L. G. exercised 56,125 shares at a strike of $2.70, increasing direct ownership by 8% to 785,750 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 985d
  Hansen Carl L. G. exercised 56,125 shares at a strike of $2.70, increasing direct ownership by 8% to 729,625 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1027d
  SEC Form 4 filed by Lecault Veronique

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1027d
  SEC Form 4 filed by Stimart Tryn

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1027d
  SEC Form 4 filed by Booth Andrew

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1027d
  SEC Form 4 filed by Hansen Carl L. G.

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1055d
  Thermopylae Holdings Ltd. gifted 210,000 shares, decreasing direct ownership by 0.37% to 55,802,493 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1077d
  Hansen Carl L. G. exercised 56,125 shares at a strike of $2.70, increasing direct ownership by 9% to 673,500 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1096d
  Montalbano John S. bought $137,400 worth of shares (30,000 units at $4.58), increasing direct ownership by 54% to 86,000 units (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1139d
  Hayden Michael R bought $98,200 worth of shares (20,000 units at $4.91) (SEC Form 4)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1151d
  SEC Form 4: Lecault Veronique bought $103,800 worth of shares (20,000 units at $5.19), increasing direct ownership by 0.99% to 2,040,122 units

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1171d
  SEC Form 4: Hansen Carl L. G. exercised 56,125 shares at a strike of $2.70, increasing direct ownership by 10% to 617,375 units

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1187d
  SEC Form 4: Hayden Michael R bought $177,000 worth of shares (30,000 units at $5.90)

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1258d
  SEC Form 4 filed by Hansen Carl L. G.

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1262d
  SEC Form 4 filed by Booth Andrew

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1262d
  SEC Form 4 filed by Thermopylae Holdings Ltd.

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)
• 1279d
  SEC Form 4 filed by Lecault Veronique

  4 - AbCellera Biologics Inc. (0001703057) (Issuer)